Self-reported ratings of sleep quality and symptoms of poor sleep have been linked to increased risk of coronary heart disease (CHD), Type 2 diabetes and hypertension with recent evidence suggesting stronger associations in women. At this time, the mechanisms of action that underlie these gender-specific associations are incompletely defined. The current study examined whether gender moderates the relation of subjective sleep and sleep-related symptoms to indices of inflammation, coagulation, insulin resistance (IR) and psychosocial distress, factors associated with increased risk of cardiovascular and metabolic disorders. Subjects were 210 healthy men and women without a history of sleep disorders. The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality and frequency of sleep symptoms. In multivariate-adjusted models, overall poor sleep quality, more frequent problems falling asleep (>2 night/week) and longer periods to fall asleep (>30 min) were associated with greater psychosocial distress, higher fasting insulin, fibrinogen and inflammatory biomarkers, but only for women. The data suggest that subjective ratings of poor sleep, greater frequency of sleep-related symptoms, and longer period of time to fall asleep are associated with a mosaic of biobehavioral mechanisms in women and that these gender-specific associations have direct implications to recent observations suggesting gender differences in the association between symptoms of poor sleep and cardiovascular disease.
Introduction
Recent evidence from large epidemiological studies has suggested that poor sleep and sleep-related problems are more strongly associated with poor health outcomes in women than in men. For example, in one study, subjective symptoms of disturbed sleep were associated with a greater risk of cardiovascular disease (CVD) in older women than in men and these associations persisted even after adjustments for potential confounders (Newman et al., 2000) . Similar findings were observed by researchers from the Whitehall II community study who showed that short sleep duration was associated with both prevalence and incidence of hypertension with these associations found to be significant only for women (Cappuccio et al., 2007) . These novel, but important, gender differences suggest that disturbances in sleep quantity and quality may be differentially associated with putative mechanisms implicated in the onset and progression of cardiovascular and metabolic diseases in men and women. To date, no study has examined mechanisms of actions that could explain the observed gender-specific differences in the relation of sleep to disease outcomes.
Researchers have postulated a number of pathways whereby poor sleep quantity and quality can contribute to poor cardiovascular and metabolic health. One set of 
